- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03262896
Neurophysiological Examination in Patients With Brain Death
October 8, 2019 updated by: Hilmi Demirkiran, MD, Yuzuncu Yıl University
Neurophysiological Study in Patients With Brain Death: A Single Center Prospective Study
This study examines muscle movements of elecromyography in adults with brain death.
Half of the participants will have brain death, the other half will be healthy volunteers.
Study Overview
Status
Completed
Conditions
Detailed Description
In some of the patients who have brain death diagnosis, some movements may be seen.
Because of these movements, the doctors sometimes avoid to make brain death diagnosis.
So making brain death diagnosis may delay.
And in these patients, even if the brain death diagnosis made the family members refuse to donate the organs of the patients because they think their patients may survive when they see muscle movements with touch.
These patients with brain death are lost in a short time, so some of the patients can not be used as donors.
In this study, the investigators aim to raise awareness the movements in brain death patients can be seen, to study the movements neurophysiologically by EMG, whether EMG can be used as auxiliary method or not in brain death diagnosis and to raise organ donation numbers from cadavers.
Investigators will examine the motor response and F response in the facial nerve, median nerve, and tibialis posterior nerve with electromyography neurophysiologically.
Study Type
Observational
Enrollment (Actual)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tusba / Zeve Kampus
-
Van, Tusba / Zeve Kampus, Turkey, 65080
- Yuzuncu Yil University, School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 72 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients in the adult intensive care unit
Description
Inclusion Criteria:
- Adult patients with definite diagnosis of brain death,
- Patients with permission from their parents,
- Patients without trauma of medullaspinalis and peripheral nerve injuries,
- Patients without previously known muscle disease (Myasthenia gravis, myopathy, etc.),
- Patients with previously unknown neurological disease (Amyotrophic Lateral Sclerosis, Multiple sclerosis, Guillain Barre syndrome, Poliomyelitis, etc.),
- Patients who have not previous systemic diseases (Connective Tissue Disease, Diabetes mellitus, Chronic renal failure, etc.).
Exclusion Criteria:
- Uncertain brain death,
- Patients without permission of family members,
- Younger than 18 years old and older than 72 years,
- Patients with medulla spinalis and peripheral nerve injuries,
- Patients with known muscle disease (Myasthenia gravis, myopathy, etc.),
- Patients with neurological disease (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Guillain Barre Syndrome, Poliomyelitis, etc.),
- Patients with previous systemic diseases (Connective Tissue Disease, Diabetes, Chronic Kidney Failure, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients with brain death
Ten patients with definite etiology, who were diagnosed with brain death because of Apnea test positive and / or cranial reflexes were not available and were male and female patients aged 18-72 years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Axonal response
Time Frame: Within 72 hours from brain death diagnosis
|
Measure of axonal response by electromyography
|
Within 72 hours from brain death diagnosis
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Hilmi Demirkiran, MD, Department of Anethesiology and Reanimation
- Principal Investigator: Aydin Cagac, MD, Department of Neurology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 15, 2017
Primary Completion (ACTUAL)
May 15, 2018
Study Completion (ACTUAL)
September 15, 2019
Study Registration Dates
First Submitted
August 19, 2017
First Submitted That Met QC Criteria
August 23, 2017
First Posted (ACTUAL)
August 25, 2017
Study Record Updates
Last Update Posted (ACTUAL)
October 10, 2019
Last Update Submitted That Met QC Criteria
October 8, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EMG in Brain Death
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Death
-
Alexandria UniversityUnknownMaternal Death | Hypoxic Brain InjuryEgypt
-
NYU Langone HealthRecruiting
-
Centre Hospitalier Universitaire de NīmesTerminatedStress Disorders, Post-TraumaticFrance
-
Liu YonghongEnrolling by invitationSudden Unexpected Death in Epilepsy | Near-Sudden Unexpected Death in EpilepsyChina
-
Hospices Civils de LyonTerminatedSudden Unexpected Death in Epilepsy (SUDEP)France
-
Fundació Institut de Recerca de l'Hospital de la...UnknownBiomarkers | Cardiac Sudden Death | Hypoxia Brain | Cell Membrane MicroparticlesSpain
-
Indiana UniversityGreenwich Biosciences; Child Neurology FoundationCompleted
-
Brigham and Women's HospitalNot yet recruitingEpilepsyUnited States
-
Gorm GreisenCopenhagen Trial Unit, Center for Clinical Intervention Research; Elsass FoundationCompletedBrain Injuries | Infant, Extremely Premature | Death; Neonatal | Death, BrainDenmark
-
Instituto de Investigación Hospital Universitario...Hospital de Santa Maria, PortugalCompletedPrevention of Kidney Injury Associated With Brain DeathSpain, Portugal